Skip to main content
. 2018 Aug 23;7(9):236. doi: 10.3390/jcm7090236

Table 2.

Incidence and Hazard ratio for Arrhythmia and Arrhythmia-associated risk factor.

Variable Event PY Rate # Crude HR (95% CI) Adjusted HR § (95% CI)
Cervical spondylosis
No 537 137,401 3.91 1.00 1.00
Yes 1441 130,269 11.1 2.82 (2.55, 3.11) *** 3.10 (2.80, 3.42) ***
Age group, year
20–49 440 108,197 4.07 1.00 1.00
50–64 787 102,519 7.68 1.87 (1.66, 2.10) *** 1.86 (1.64, 2.11) ***
≥65 751 56,953 13.2 3.19 (2.83, 3.59) *** 2.68 (2.33, 3.10) ***
Sex
Female 1134 158,588 7.15 1.00 1.00
Male 844 109,082 7.74 1.07 (0.98, 1.17)
Occupation
White collar 887 135,455 6.55 1.00 1.00
Blue collar 761 96,808 7.86 1.21 (1.10, 1.33) *** 1.11 (1.00, 1.23) *
Others & 330 35,407 9.32 1.43 (1.26, 1.62) *** 1.22 (1.07, 1.39) **
Urbanization level
1 (highest) 615 88,016 6.99 1.00 1.00
2 584 81,759 7.14 1.02 (0.91, 1.15) 1.01 (0.90, 1.14)
3 313 42,595 7.35 1.05 (0.92, 1.21) 1.05 (0.92, 1.20)
4(lowest) 466 55,300 8.43 1.21 (1.07, 1.36) ** 1.07 (0.94, 1.22)
Comorbidity
Diabetes
No 1756 241,894 7.26 1.00 1.00
Yes 222 25,776 8.61 1.17 (1.01, 1.34) * 0.86 (0.75, 1.00)
Hypertension
No 877 169,015 5.19 1.00 1.00
Yes 1101 98,655 11.2 2.13 (1.95, 2.33) *** 1.75 (1.55, 1.97) ***
Hyperlipidemia
No 1200 188,751 6.36 1.00 1.00
Yes 778 78,919 9.86 1.54 (1.40, 1.68) *** 1.44 (1.30, 1.59) ***
CAD
No 1261 218,556 5.77 1.00 1.00
Yes 717 49,114 14.6 2.51 (2.29, 2.75) *** 1.94 (1.74, 2.17) ***
Stroke
No 1885 258,451 7.29 1.00 1.00
Yes 93 9219 10.1 1.35 (1.10, 1.67) ** 0.72 (0.58, 0.89) **
CKD or ESRD
No 1939 264,481 7.33 1.00 1.00
Yes 39 3189 12.2 1.61 (1.17, 2.21) ** 0.93 (0.67, 1.29)
COPD
No 1569 233,782 6.71 1.00 1.00
Yes 409 33,888 12.1 1.77 (1.59, 1.98) *** 1.42 (1.27, 1.60) ***
Cancer
No 1917 261,697 7.33 1.00 1.00
Yes 61 5973 10.2 1.36 (1.05, 1.75) * 1.18 (0.91, 1.53)
CHF
No 1878 262,212 7.16 1.00 1.00
Yes 100 5458 18.3 2.49 (2.04, 3.04) *** 1.24 (1.00, 1.54) *
Sleep apnea
No 1968 266,718 7.38 1.00 1.00
Yes 10 952 10.5 1.34 (0.72, 2.49)
Medication
NSAID
No 1003 136,500 7.35 1.00 1.00
Yes 975 131,170 7.43 1.12 (1.02, 1.23) * 2.49 (2.25, 2.75) ***
All Beta blocker
No 915 165,352 5.53 1.00 1.00
Yes 1063 102,318 10.4 1.85 (1.69, 2.02) *** 1.20 (1.03, 1.39) *
Propranolol
No 1227 197,835 6.20 1.00 1.00
Yes 751 69,835 10.8 1.71 (1.56, 1.87) *** 1.43 (1.25, 1.64) ***
Carvedilol
No 1886 260,263 7.25 1.00 1.00
Yes 92 7407 12.4 1.65 (1.34, 2.04) *** 0.79 (0.64, 0.99) *
Bisoprolol
No 1830 255,203 7.17 1.00 1.00
Yes 148 12,467 11.9 1.59 (1.34, 1.88) *** 0.74 (0.62, 0.89) **

CI, confidence interval; COPD, chronic obstructive pulmonary disease; CKD, chronic kidney disease; HR, hazard ratio; PY, person-years; # Incidence rate per 1000 person-years; § Model was adjusted for age, sex, frequency of medical visits/per year, occupation, urbanization level, comorbidity of diabetes, hypertension, hyperlipidemia, CAD, stroke, CKD or ESRD, COPD, cancer, CHF, and medications of NSAID, beta blocker, propranolol, carvedilol, and bisoprolol by using Cox proportional hazards regression; The urbanization level was categorized by the population density of the residential area into 4 levels, with level 1 as the most urbanized and level 4 as the least urbanized. & Other occupation categories included those who were primarily retired, unemployed, and low-income populations. * p < 0.05, ** p < 0.01, *** p < 0.001.